Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer...( SAN FRANCISCO Sept. 7 /- Roche an...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
Date:9/7/2007
SAN FRANCISCO, Sept. 7 /PRNewswire/ -- Roche announced today that three clinical data abstracts about its oral chemotherapy treatment Xeloda have been accepted for presentation at the 2007 Breast Cancer Symposium in San Francisco, Sept. 7 and 8.
Two of the abstracts include data from the XeNA (Xeloda in NeoAdjuvant) trial, a study of Xeloda and docetaxel with or without Herceptin in patients with invasive breast cancer. The third presentation highlights findings that validate efficacy and cost benefits of Xeloda in breast cancer patients.
-- Poster No. A54, [General Poster Session A, Sept. 7, 12:00 - 12:45
p.m.], "Frequency of circulating tumor cells (CTCs) in an open-label
study of neoadjuvant capecitabine, docetaxel and trastuzumab (CDT)
combination therapy in patients with HER2+ breast cancer (BC)."
(Presenter: Stefan Gluck)
-- Poster No. 100, [General Poster Session C, Sept. 8, 7:00 - 8:00 a.m.],
"Distribution of p53 mutations by AmpliChip assay in patients receiving
neoadjuvant capecitabine (C) plus docetaxel (D) with or without
trastuzumab (T) for newly diagnosed breast cancer (BC)." (Presenter:
Nancy Patten)
-- Poster No. A41, [General Poster Session D, Sept. 8, 11:45 a.m. - 12:45
p.m.], "Capecitabine is associated with fewer adverse events than other
standard therapies in patients with breast cancer: a claims database
analysis." (Presenter: Hope Rugo, M.D.)
These studies affirm Roche's commitment to exploring the expanded use of Xeloda in combination with new therapies. Additionally, the data explore the potential of oral Xeloda to offer effective treatment with a lower incidence of adverse events compared with traditional intravenous chemotherapy.
About Xeloda
Xeloda is the only FDA-approved oral chemotherapy for both metastatic
breast cancer and adjuvant and metastatic colorectal cancer. Inactive in
pill for
'/>"/>
| SOURCE Roche Copyright©2007 PR Newswire. All rights reserved |
Related medicine technology :
1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:11/6/2009)...v. 6 Repossessions and liquidation...hird quarter of 2009 declined as compared to simil...nagement,s NasTrac Quarterly Index (NQI). The fig...or both repossessions and orderly liquidations, al...truction and printing equipment, offering mixed ne...
(Date:11/6/2009)...ov. 6 Derma Sciences, ...dvanced wound care products, announced plans to re... on Monday, November 16, 2009. The Company will ho...results at 11:00 am EST. Interested parties should...(international), with passcode 81416481 to access ...
(Date:11/6/2009)...Nov. 6 Philips Respironics applaud...nd Prevention (CDC) to raise awareness about an im...ficiency. The CDC,s release of the first-ever gove... in sleeplessness is a milestone in quantifying th...time educator, industry leader and sleep therapy m...
Breaking Medicine Technology:NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2REGiMMUNE presents enhanced efficacy data in preclinical transplantation models 8669 1REGiMMUNE presents enhanced efficacy data in preclinical transplantation models 8669 2Ryder System Inc Joins the American Red Cross Annual Disaster Giving Program 47436 1Ryder System Inc Joins the American Red Cross Annual Disaster Giving Program 47436 2Ryder System Inc Joins the American Red Cross Annual Disaster Giving Program 47436 3Ryder System Inc Joins the American Red Cross Annual Disaster Giving Program 47436 4RecoveryPlanner and RiskWatch Partner to Deliver an Integrated Business Continuity Risk Management Software Solution 47433 1RecoveryPlanner and RiskWatch Partner to Deliver an Integrated Business Continuity Risk Management Software Solution 47433 2[0] NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009[0] Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call[0] Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation
...roval Based on Updated Results Showing a 20% Reduc... Improvement of Disease Free Survival at F...y -, BRIDGEWATER, N.J., May 28 Sanofi-aventis U....inistration (FDA) approved,the supplemental new dr...survival analysis from the MOSAIC trial in the Elo...
...se III study performed solely in high risk node-ne... in Disease Free Survival (DFS), BRIDGEWATER, N.J...l de Investigacion en Cancer de Mama) announced to...rly stage breast cancer,adjuvant treatment (post s...centrate as part of the TAC regimen (Taxotere(R), ...
Other Medicine Technology:New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 2New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 3New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 4Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy 2Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy 3Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy 4Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy 5(Date:11/9/2009)... , SAN DIEGO, Nov. 9 HUYA B...hina,s biopharmaceutical innovation, today announc...cine and Pharmacy, Ocean University of China. The ... that HUYA has established with China,s leading re...accelerate the global development and commercializ...
(Date:11/9/2009)... , A new study finds that women treated for breas...f they have dense breasts. Published in the Decemb...rnal of the American Cancer Society, the study,s r...ense breasts may benefit from additional therapies...s studies indicate that women with dense breast ti...
(Date:11/8/2009)... , WASHINGTON, Nov. 8 /PRNewswire-USNewswire/..., issued the following statement about the passage...s us and the American voters a lot about core valu...ur core values, seeking to overcome the struggles ...ruggles mean that many cannot afford basic healthc...
(Date:11/8/2009)... , AARP Praises House Passage of Health Care...rengthen Medicare, improve coverage for all Americ...SNewswire/ -- ,, SUMMARY: Last night the Uni...l health care reform legislation that would streng...y insurance companies that prices millions of Amer...
(Date:11/8/2009)... Ignoring pain now can take you out of the game l...althDay News) -- Foot injuries are the talk of the...back Eli Manning and running back Willie Parker. ,...sociation and American Academy of Podiatric Sports...ir feet when they play fall sports like football a...
Breaking Medicine News(10 mins):Health News:HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China 2Health News:Breast density associated with increased risk of cancer recurrence 2Health News:Catholics for Choice Statement on Healthcare Reform Bill 2Health News:AARP Pennsylvania Key Vote News Alert 2Health News:AARP Pennsylvania Key Vote News Alert 3Health News:AARP Pennsylvania Key Vote News Alert 4Health News:Rx for Fall Foot Injuries 2[0] HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China[0] Breast density associated with increased risk of cancer recurrence[1] Catholics for Choice Statement on Healthcare Reform Bill[1] AARP Pennsylvania Key Vote News Alert[0] Rx for Fall Foot Injuries
...y the World Health Organization in India has revea...al areas (approximately 21.6) outnumber those livi...prevalence of diabetes in rural India has increase...2 crore 'Rural Diabetes Project'. The provision of...
...ton University immunologist and author of the stud...tes in mice//. The main aim of the cure is to prev...lin-producing cells in the pancreas. There is a wi...ed in the journal Science. In this study the resea...
...common cancer in a woman over the world with over ...story of breast cancer//, early puberty, late meno...or breast cancer.
Dr Vincent Vinh-Hung, of U...45 yrs of age. According to researchers and scient...
...confirmed reports from government health officials...ambodian girl has died// of H5N1 bird flu. She is ...South-East Asian Nation.
The girl, Mon Puth...spokeswoman Megge Miller, the girl is a confirmed ...
...mpted to introduce a new mental health law after M...of Lin and her daughter Megan Russell// in 1998. ...sychopath, he could not be detained under the exis...conditions’ under the law so that those with dange...
...nce stands substantiated in yesterday’s ruling by ...ate treatment// measures to a lady patient who had...f’s ruling, the lady might have survived, had she ...ue to negligence of the staff at St John's Hospita...
Other Medicine News:Health News:Rural India To Benefit From New Diabetes Project 2Health News:Type 1 diabetes has a cure? 2Health News:Breast Cancer More Serious For Younger Patients 2Health News:New Twist To The Mental Health Law 2Sebban Phaco Chopper, double end
Alio-Rosen Phaco PreChopper
A.W.Brown Nucleus Cracker
Ernest Nucleus Cracker
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |